ACP can be considered fully penetrant if the primary discriminating phenotype causing the clinically significant symptoms is taken into account (i.e., loss of CP function due to structural or missense mutations in the CP gene, causing neurological, hepatic, haematological, diabetes and retinal degeneration.6 This evidence concerns the gene CP and retinal degeneration.